The Defence Medical Command (DMedC) has launched a new research strategy, urging partners across the UK's defence, academic, business, and research sectors to collaborate in advancing military healthcare and medicine. This comprehensive plan provides a unified direction for defence medical research, prioritising support for personnel, improving patient care, and strengthening operational readiness in a significantly altered global geopolitical landscape.
The strategy marks a notable shift in approach for Defence Medical, moving its research priorities from counterinsurgency operations to the demands of high-intensity, large-scale conflict. This change reflects the insights from last year's Strategic Defence Review, which highlighted the necessity for the UK's Armed Forces to be prepared for major combat scenarios. Philip Woodgate, Director of Research in Defence Medical, stated that the strategy is designed to meet this challenge head-on, ensuring research and development are focused and aligned with operational needs in both peace and wartime.
Collaboration is central to the DMedC's new strategy. It explicitly acknowledges that achieving the required scale of innovation in military medicine cannot be done in isolation. Therefore, it seeks to work closely with organisations such as the Defence Science and Technology Laboratory, UK Defence Innovation, academic institutions, and industry partners who provide essential specialist expertise and infrastructure. This collaborative model aims to create a single, clear demand signal for defence medical research, aligning effort and investment across numerous organisations.
The tangible benefits anticipated from this new direction are significant. These include improved deployability of personnel, a greater number of lives saved on the battlefield, faster recovery times, and a quicker return to duty for service members. Furthermore, the strategy aims to deliver better long-term health outcomes for all defence personnel. While success will be measured through increased research activity, funding, and collaboration, the ultimate goal is real-world impact.
By 2031, the DMedC envisions a future where research directly shapes defence policy and clinical practice, leading to an improved quality of care for patients. Ultimately, the strategy aims to cultivate a force that is better prepared to meet the complex medical demands of large-scale combat operations. All DMedC staff and partners are encouraged to use the strategy as the primary demand signal when engaging with collaborators, ensuring a unified approach that will contribute to shaping future priorities as the document evolves.